463 related articles for article (PubMed ID: 9078197)
1. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P
Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197
[TBL] [Abstract][Full Text] [Related]
2. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
Malik M; Camm AJ; Janse MJ; Julian DG; Frangin GA; Schwartz PJ
J Am Coll Cardiol; 2000 Apr; 35(5):1263-75. PubMed ID: 10758969
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Cairns JA; Connolly SJ; Roberts R; Gent M
Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
[TBL] [Abstract][Full Text] [Related]
4. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.
Jafri SM; Borzak S; Goldberger J; Gheorghiade M
Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmic risk stratification of post-myocardial infarction patients.
Naccarella F; Lepera G; Rolli A
Curr Opin Cardiol; 2000 Jan; 15(1):1-6. PubMed ID: 10666655
[TBL] [Abstract][Full Text] [Related]
6. The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators.
Camm AJ; Julian D; Janse G; Munoz A; Schwartz P; Simon P; Frangin G
Am J Cardiol; 1993 Nov; 72(16):95F-98F. PubMed ID: 8237837
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P;
Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.
Farré J; Romero J; Rubio JM; Ayala R; Castro-Dorticós J
Am J Cardiol; 1999 Mar; 83(5B):55D-63D. PubMed ID: 10089841
[TBL] [Abstract][Full Text] [Related]
9. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
[TBL] [Abstract][Full Text] [Related]
10. The azimilide post-infarct survival evaluation (ALIVE) trial.
Camm AJ; Karam R; Pratt CM
Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
[TBL] [Abstract][Full Text] [Related]
11. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).
Janse MJ; Malik M; Camm AJ; Julian DG; Frangin GA; Schwartz PJ
Eur Heart J; 1998 Jan; 19(1):85-95. PubMed ID: 9503180
[TBL] [Abstract][Full Text] [Related]
12. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.
Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164
[TBL] [Abstract][Full Text] [Related]
13. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
Yap YG; Camm AJ
Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
[TBL] [Abstract][Full Text] [Related]
14. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
15. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
Køber L; Bloch Thomsen PE; Møller M; Torp-Pedersen C; Carlsen J; Sandøe E; Egstrup K; Agner E; Videbaek J; Marchant B; Camm AJ;
Lancet; 2000 Dec; 356(9247):2052-8. PubMed ID: 11145491
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone: clinical trials.
Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
[TBL] [Abstract][Full Text] [Related]
17. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
Stevenson WG; Ridker PM
JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS).
Burkart F; Pfisterer M; Kiowski W; Follath F; Burckhardt D
J Am Coll Cardiol; 1990 Dec; 16(7):1711-8. PubMed ID: 2254558
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.
Boutitie F; Boissel JP; Connolly SJ; Camm AJ; Cairns JA; Julian DG; Gent M; Janse MJ; Dorian P; Frangin G
Circulation; 1999 May; 99(17):2268-75. PubMed ID: 10226092
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
Gambhir DS
Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
